Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 09:32:12 GMT 2025
by
admin
on
Wed Apr 02 09:32:12 GMT 2025
|
| Protein Type | PEPTIDE |
| Protein Sub Type | |
| Sequence Origin | SYNTHETIC |
| Sequence Type | COMPLETE |
| Record UNII |
DB2XB649O5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C211765
Created by
admin on Wed Apr 02 09:32:12 GMT 2025 , Edited by admin on Wed Apr 02 09:32:12 GMT 2025
|
PRIMARY | |||
|
2988012-71-9
Created by
admin on Wed Apr 02 09:32:12 GMT 2025 , Edited by admin on Wed Apr 02 09:32:12 GMT 2025
|
PRIMARY | |||
|
DB2XB649O5
Created by
admin on Wed Apr 02 09:32:12 GMT 2025 , Edited by admin on Wed Apr 02 09:32:12 GMT 2025
|
PRIMARY | |||
|
13396
Created by
admin on Wed Apr 02 09:32:12 GMT 2025 , Edited by admin on Wed Apr 02 09:32:12 GMT 2025
|
PRIMARY |
| Linkage Type | Residue Index | |||
|---|---|---|---|---|
| CROSSLINK | 1_1 | 2_1 | 3_1 | 4_1 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
In COVID-19 patients, Tie2 activation is compromised owing to the high level of circulating Angioppoietin-2 (Angp-2), an antagonist of Angpt-1, leading to lung vasculature inflammation along with EC apoptosis and permeability, triggering ARDS
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_1] [2_1] [3_1] [4_1] | SITE_SPECIFIC | Pegevongitide histidine modification | IDL31SQ6LT |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|